Weekly Alert Rebounding this week with the first and overlooked news on VA’s $1B Home Telehealth awards, Apple Watch OS10’s enhanced health features, why Nox anted up $3M for Pear assets, and looking at EHRs outside the US. ‘Watch your fisc’ advice for startups moving from A to B. And in with the new with AI news. VA awards four remote patient monitoring companies to share in $1B Home Telehealth contract (Medtronic wins again plus 3 newbies) Friday roundup: VA Spokane quashes staff cuts; EHR market share ex-US; Epic’s proposed UK HQ expansion; Apple watchOS 10 adds health features; Nox Health on Pear buy; GP2U Telehealth sold Watch your cash burn! Now 31 months average for startups between Series A and B. Now what do you do? (Cautionary advice for startups) AI news: GE HealthCare’s 510(k) for Precision DL (+ GE stake sale), Samsung adopts care.ai for in-facility patient monitoring, Mayo Clinic-Google Cloud generative AI, Wolters Kluwer buys Invistics for drug diversion detection (Getting in on the act) ISfTeH Student Contest and Award 2023, Friday 16 June (Drop in via Zoom for the last 4) A short list of news this post-holiday week along with Perspectives on AI and ML. Continuing the trend of finishing off the old (Theranos, insurtechs, Cerner, Pear–see update), dealing with the consequences, and moving towards Known Unknowns. Perspectives: How AI and ML can accelerate the growth of telemedicine across the globe (Thoughtful take on the up-and-downsides of both) Mid-week roundup: Holmes turns herself in, ChatGPT as good ER explainer, VA Spokane to cut staff to pay for Oracle Cerner EHR problems?, former Cerner campus conversion (Last chapters in the Theranos Saga and Cerner. New chapter with ChatGPT in ERs.) Global digital health funding steadies as the debris clears after the 2022 implosion, Bright sells off Zipnosis, and a few surprises with Pear Therapeutics Ch. 11 selloff and where assets are going. Flat is Good: CB Insights’ Q1 global digital funding, deal numbers finally steady (Let’s see what Q2 brings) Another Bright Health selloff: Zipnosis sold to Florence Labs (This took place in March–why the announcement delay?) Mid-week roundup: Pear assets fetch paltry $6M *updated*, Bright Health’s reverse stock split, Oracle Cerner loses hospital EHR share, Lifeforce health optimization scores $12M Series A (The table continues to clear. And new revelations about Pear’s founder McCann being a successful bidder.) A better look at the Kaiser-Geisinger Risant Health setup, VA renews Oracle for EHR–with conditions and Congressional scrutiny. Holmes nears her appointment in Texas and owes $452M. And up and down on the business rollercoaster with Envision, Validic-Trapollo, CVS Health’s exit of clinical trials, fundings, and continuing problems at Owlet and Veradigm. Thursday roundup: Kaiser-Geisinger won’t close till ’24, Validic buys Trapollo, Veradigm’s ’22 financials delayed again, ORA telehealth’s $10M Series A, ATA adds 3 to board (Much more to Kaiser-Geisinger Risant Health deal–here’s the key info) VA renews Oracle Cerner EHR contract, but with multiple caveats, metrics, and annual renegotiations (Oracle and VA remain on the Congressional griddle) Breaking & updated–Time’s Up! Ninth Circuit Court to Elizabeth Holmes: proceed to Federal prison. District Court: surrender 30 May, pay $452M in restitution with Sunny. (Elizabeth may have done the crime, but Liz will do the time) Monday roundup: Envision files Ch. 11, who’s to blame for Meta Pixel abuse?, CVS Health to shut clinical trials unit, Amino Health scoops $80M, DocGo flat but optimistic, Owlet way down in revenue (Companies new and old struggle financially, technologically) And of continued interest from previous weeks…. News roundup: Cano Health board fight, board shakeup; Memora Health’s $30M raise; Teladoc enters weight management race (A battle of the giants brewing at Cano?) Insurtechs in the widening gyre: Bright Health sued for claims non-payment, fined $1M by Colorado; Clover Health lays off 10%, outsources operations (This centre may not be holding) Short takes: Amazon dims to black Halo wearable line, eVisit acquires Bluestream Health, Moving Health Home launches to lobby Congress, government (More consolidation) Mid-week roundup: Kaiser Permanente to buy Geisinger, setup separate system; GoodRx co-CEOs step down; strong earnings for Centene, Humana; Clover Health stock woes, settles $22M lawsuit (Consolidation and pivoting) Week-end roundup: Cano Health’s $60M loss and divesting, Oscar Health exits CA, UCSF Meta Pixel lawsuit narrows, Syneos goes private for $7.1B, Envision nears Ch. 11, Australia’s A$429M EHR modernization funded (Cano Health drama goes on) Babylon Health ‘Take Private Proposal’ includes London High Court administration request (The real dirt in the 8-K) Mid-week roundup: DEA extends telehealth prescribing waiver to November; telehealth usage continues to erode; NextGen EHR hacked, 1M records breached (A short stay of sentence for telemental health prescribers dependent on controlled substances) Babylon Health to go private in June as shares plummet, Q1 loss increases 117% (AlbaCore taking over? Shares are a buck!) Have a job to fill? Seeking a position? See jobs listed with our new job search partner Jooble in the right sidebar! Read Telehealth and Telecare Aware: http://telecareaware.com/ @telecareaware Follow our pages on LinkedIn and on Facebook We thank our advertisers and supporters: Legrand/Tynetec, Eldercare, UK Telehealthcare, ATA, The King’s Fund, DHACA, HIMSS, MedStartr, and Parks Associates. Reach international leaders in health tech by advertising your company or event/conference in TTA–contact Donna for more information on how we help and who we reach. Telehealth & Telecare Aware: covering the news on latest developments in telecare, telehealth, telemedicine, and health tech, worldwide–thoughtfully and from the view of fellow professionals Thanks for asking for update emails. Please tell your colleagues about this news service and, if you have relevant information to share with the rest of the world, please let me know. Donna Cusano, Editor In Chief [email protected] – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
This content was originally published here.
